Tesamorelin
Reduces visceral fat and improves metabolism.
$232
A synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the release of human growth hormone (HGH).
- FDA-approved for HIV-associated lipodystrophy, with demonstrated effects on fat loss, muscle preservation, nerve regeneration, and cognitive support.
- Not a steroid and does not affect testosterone levels.
- Studied for reduced visceral fat and improved body composition while preserving lean muscle.
- Explored for nervous system recovery and key neurotransmitters involved in cognitive function.
1
Dosing schedule
Concentration
10 mg/ml, total 3 ml, total 30 mg
Frequency
Daily
Dose
10
Duration
1 Month
Break
1 Month
A growth hormone-releasing factor (GHRF) analog that reduces visceral fat in HIV-associated lipodystrophy and may support metabolic health.
For research use only. Not for human consumption. Not evaluated by the FDA.